Nasdaq
$2.86▲ 0.35%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $134.7MShares out 47.1M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
15- 10.16After-hours26.10.17 05:084Ownership#●●●
Quanterix Corp
Quanterix Corp insider Michael Francis Miller reported a change in beneficial ownership of securities as of October 15, 2026. This filing serves as the official disclosure of the insider's equity transaction via Form 4.…more
$2.86+0.35%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.2After-hours26.10.03 05:054Ownership
Quanterix Corp
Ivana Magovcevic-Liebisch, a director of Quanterix Corporation, has executed a Power of Attorney to authorize designated representatives to file SEC reports, including Forms 3, 4, 5, and Schedules 13D and 13G, on her behalf. This action facilitates compliance with Section 13 and 16 of the Securities Exchange Act of 1934.…more
$2.86+0.35%vs prev closeView filingShare - 10.2After-hours26.10.03 05:024Ownership
Quanterix Corp
Insider Mendel Scott of Quanterix Corp reported a change in beneficial ownership of securities as of October 1, 2026. This filing is a standard disclosure of insider equity transactions via Form 4.…more
$2.86+0.35%vs prev closeView filingShare
14 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.7Pre-market26.10.07 21:02#●●●#●●●
Quanterix Secures Regulatory Approval for SIMOA Technology in China
Quanterix and Innovita Biological Technology have received regulatory approvals to introduce SIMOA technology and neurology biomarker testing in China. This development marks a significant step in expanding the company's precision biomarker science footprint within the Chinese market.…more
$2.86+0.35%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga